Acumen Pharmaceuticals
ABOS----
Forecast & Rating6 analysts currently cover Acumen Pharmaceuticals, with about 16.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $1.00, about 317.2% upside from the current price of $0.24. For you, this means most institutions are cautious on Acumen Pharmaceuticals's outlook. Data as of Nov 2, 2026; for reference only and not investment advice.
Nov 2, 2026Price forecast
$1.00317.19%
Forecast & RatingHold
6analysts
- Strong buy16.67%
- Buy0.00%
- Hold50.00%
- Sell16.67%
- Strong sell16.67%
Target price forecast
Forecast dateNov 2, 2026
Forecast met0.0%
Stock price$0.24
Avg. target$6.4
High target$10
Low target$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.